Jackson Square Partners’s Twist Bioscience TWST Stock Holding History

Jackson Square Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,333,523	Closed	-$31.8M	–	84
2022 Q4	$31.8M	Sell	1,333,523 -89,860	-6%	-$2.61M	0.85%	31
2022 Q3	$50.2M	Sell	1,423,383 -1,075,548	-43%	-$45.7M	1.32%	28
2022 Q2	$87.4M	Buy	2,498,931 +1,272	+0.1%	+$45.1K	2.04%	23
2022 Q1	$123M	Buy	2,497,659 +686,718	+38%	+$38.1M	1.22%	33
2021 Q4	$140M	Buy	1,810,941 +256,862	+17%	+$26.4M	1.18%	36
2021 Q3	$166M	Buy	1,554,079 +246,842	+19%	+$28.3M	1.05%	39
2021 Q2	$174M	Buy	1,307,237 +25,123	+2%	+$2.92M	1%	44
2021 Q1	$159M	Buy	1,282,114 +1,275,735	+19,999%	+$194M	0.9%	49
2020 Q4	$901K	Sell	6,379 -2,422	-28%	-$269K	﹤0.01%	83
2020 Q3	$668K	Sell	8,801 -67,209	-88%	-$4.18M	﹤0.01%	78
2020 Q2	$3.44M	Buy	+76,010	New	+$2.73M	0.02%	78

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jackson Square Partners's TWST Position: Q1 2023 in Review

Jackson Square Partners sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 1,333,523 shares — an estimated $31.8M sold.

Jackson Square Partners first reported a position in TWST in Q2 2020 and held it in 11 quarters. The position peaked at $174M in Q2 2021. 202 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

Jackson Square Partners reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
Jackson Square Partners sold 1,333,523 Twist Bioscience shares in Q1 2023, an estimated $31.8M.
Jackson Square Partners first reported a position in Twist Bioscience in Q2 2020 and held it in 11 quarters.
Jackson Square Partners's Twist Bioscience position peaked at $174M in Q2 2021.
202 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Jackson Square Partners's 13F filing for Q1 2023, filed 11 May 2023.